New Lexapro Class Action Can't Tag Onto MDL

Law360, New York (May 28, 2009, 12:00 AM EDT) -- A federal judge has shot down a bid to consolidate a newly filed proposed class action with multidistrict litigation over Lexapro and Celexa, saying the new product liability lawsuit asserts allegations relating to Forest Laboratories Inc.'s marketing of the drugs, while the MDL relates only to damages for personal injuries arising from suicidality.

Judge Rodney W. Sippel said in a ruling Thursday in the U.S. District Court for the Eastern District of Missouri that Universal Care Inc., one of the plaintiffs in the proposed class action,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.